VolitionRx Limited (VNRX) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
VolitionRx Limited (VNRX) Bundle
Discover the true potential of VolitionRx Limited (VNRX) with our advanced DCF Calculator! Adjust essential assumptions, explore various scenarios, and evaluate the effects of changes on VolitionRx Limited (VNRX) valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .1 | .3 | .8 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Revenue Growth, % | 0 | -21.43 | 570.25 | 240.3 | 153.04 | 69.64 | 69.64 | 69.64 | 69.64 | 69.64 |
| EBITDA | -15.1 | -19.2 | -25.7 | -29.2 | -34.0 | -1.3 | -2.2 | -3.8 | -6.4 | -10.9 |
| EBITDA, % | -88149.71 | -143140.95 | -28532.04 | -9542.34 | -4391.04 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .9 | 1.0 | 1.1 | 1.2 | 1.4 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Depreciation, % | 5278.5 | 7752.35 | 1271.91 | 387.88 | 182.29 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -16.0 | -20.3 | -26.8 | -30.4 | -35.5 | -1.3 | -2.2 | -3.8 | -6.4 | -10.9 |
| EBIT, % | -93428.21 | -150893.3 | -29803.95 | -9930.21 | -4573.33 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 17.0 | 19.4 | 20.6 | 10.9 | 20.7 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Total Cash, percent | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .1 | .2 | .3 | .5 | .9 | 1.6 | 2.7 |
| Account Receivables, % | 0 | 52.99 | 13.89 | 23.7 | 31.29 | 24.37 | 24.37 | 24.37 | 24.37 | 24.37 |
| Inventories | .0 | .3 | .6 | .8 | .0 | .8 | 1.3 | 2.3 | 3.9 | 6.5 |
| Inventories, % | 0 | 2256.96 | 664.59 | 256.18 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | .6 | 1.5 | 1.5 | 3.0 | 3.2 | 1.3 | 2.2 | 3.8 | 6.4 | 10.9 |
| Accounts Payable, % | 3669 | 11460.93 | 1713.17 | 993.17 | 414.2 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.5 | -1.9 | -1.0 | -1.6 | -1.1 | -1.3 | -2.2 | -3.8 | -6.4 | -10.9 |
| Capital Expenditure, % | -2990.56 | -14449.94 | -1081.31 | -512.47 | -139.78 | -100 | -100 | -100 | -100 | -100 |
| Tax Rate, % | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITAT | -15.9 | -20.4 | -26.8 | -30.1 | -35.1 | -1.3 | -2.2 | -3.8 | -6.4 | -10.8 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -14.9 | -20.6 | -26.9 | -29.2 | -34.0 | -4.1 | -2.1 | -3.5 | -6.0 | -10.1 |
| WACC, % | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -19.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -10 | |||||||||
| Terminal Value | -147 | |||||||||
| Present Terminal Value | -95 | |||||||||
| Enterprise Value | -114 | |||||||||
| Net Debt | -15 | |||||||||
| Equity Value | -99 | |||||||||
| Diluted Shares Outstanding, MM | 71 | |||||||||
| Equity Value Per Share | -1.40 |
What You Will Receive
- Authentic VNRX Financial Data: Pre-populated with VolitionRx Limited’s historical and forecasted data for accurate analysis.
- Completely Customizable Template: Easily adjust essential inputs such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Watch the intrinsic value of VNRX update in real-time as you make modifications.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: User-friendly layout and straightforward guidelines suitable for all skill levels.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue projections, gross margins, and R&D expenses.
- Instant DCF Valuation: Automatically computes intrinsic value, net present value, and additional financial metrics.
- High-Precision Analysis: Leverages VolitionRx's actual financial data for accurate valuation results.
- Streamlined Scenario Testing: Easily evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Avoid the complexity of constructing intricate valuation models from the ground up.
How It Works
- Download the Template: Get instant access to the Excel-based VNRX DCF Calculator.
- Input Your Assumptions: Adjust the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically updates VolitionRx's intrinsic value.
- Test Scenarios: Simulate various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for VolitionRx Limited (VNRX)?
- All-in-One Solution: Offers DCF, WACC, and financial ratio analyses tailored for VolitionRx Limited (VNRX).
- Flexible Parameters: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes VolitionRx Limited’s (VNRX) intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable foundations for analysis.
- Expert-Level Tool: Perfect for financial analysts, investors, and consultants focused on VolitionRx Limited (VNRX).
Who Should Use VolitionRx Limited (VNRX)?
- Investors: Gain insights and make informed decisions with advanced diagnostic tools.
- Healthcare Professionals: Utilize innovative technology to improve patient outcomes and diagnostics.
- Researchers: Adapt our solutions for clinical studies and data analysis.
- Biotech Enthusiasts: Explore the latest advancements in cancer detection and diagnostics.
- Educators and Students: Leverage real-world applications of biotechnology in academic settings.
What the Template Contains
- Historical Data: Includes VolitionRx Limited's (VNRX) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate VolitionRx Limited's (VNRX) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of VolitionRx Limited's (VNRX) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.